Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker. - Avenali, M.; Caminiti, S.P.; Gegg, M.; Cerri, S.; Mitrotti, P.; Bandirali, L.; Toffoli, M.; Hughes, D.; Cerami, C.; Tassorelli, C.; Valente, E.M.; Schapira, A.H.V.; et al. (Parkinsonism & Related Disorders, 2025)